AstraZeneca sets out $15 billion China investment during Starmer visit

January 29, 2026

UK drugmaker AstraZeneca said on Thursday it would invest $15 billion in China through 2030 to expand medicines manufacturing and research and development, an announcement made during British Prime Minister Keir Starmer’s visit to Beijing.

Search

RECENT PRESS RELEASES

Apple Stock (AAPL) Edges Higher After Earnings — What Investors Are Focusing on Now

SWI Editorial Staff2026-01-30T00:05:02-08:00January 30, 2026|

Bitcoin’s Value vs Gold Nears 2017 Levels Despite “Hype,” Peter Schiff Says

SWI Editorial Staff2026-01-30T00:02:48-08:00January 30, 2026|

Bitcoin price today: slumps to $83k as heavy liquidations, Fed uncertainty weigh By Invest

SWI Editorial Staff2026-01-30T00:02:04-08:00January 30, 2026|

US returns to Africa with investment-first strategy as competition for influence intensifi

SWI Editorial Staff2026-01-30T00:00:47-08:00January 30, 2026|

Ethereum Price Dumps To $2,700, Bulls Scramble To Defend Support

SWI Editorial Staff2026-01-29T23:59:15-08:00January 29, 2026|

Fidelity launches FIDD on Ethereum – Could this boost ETH?

SWI Editorial Staff2026-01-29T23:58:20-08:00January 29, 2026|